The most well-known active transporter is P-gp, which is located in the syncytiotrophoblast (apical membranematernal side), acting as a pump transport molecule from inside the cell to the extracellular space [85,86] and also functioning as a barrier by protecting the fetus when exposed to xenobiotics
Here is where the public conversation goes off the rails: weight regain after stopping treatment is being framed as evidence that treatment is not worth it, or that patients are stuck on it for life, as if that is a moral failing or some unique downside in obesity care
The team may also request lab work to assess your hormone levels if you find it difficult to lose weight or if you continue to gain weight despite a healthy lifestyle
I've always enjoyed lifting weights," Metz told the news outlet, adding that she has a preference for cardio
This review aims to increase the awareness and vigilance of healthcare providers in recognizing and managing the dermatological side effects of DPP-4 inhibitors and to emphasize the need for further research and surveillance to optimize diabetes care and patient safety
Transition considerations The switch from tirzepatide to orforglipron does not happen overnight
